Clinical Trials Browser

Phase 1/2 × Completed × Tetanus Toxoid × Clear all

NCT02737475 2022-01-25

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

Phase 1/2 Completed

166 enrolled 57 charts

Advanced Cancer